Nuclear Medicine and Biology

Top Research Topics at Nuclear Medicine and Biology?

The aim of Nuclear Medicine and Biology is to expand the discussion of research in In vivo, Biodistribution, Stereochemistry, Biochemistry and In vitro. In vivo research presented in the journal encompasses a variety of subjects, including Receptor, Pharmacology, Molecular biology and Pathology. The presentations focused mostly on Receptor in an attempt to further explore topics in Internal medicine.

The study on Molecular biology presented in it intersects with the topics under Monoclonal antibody. Nuclear Medicine and Biology covers Monoclonal antibody research under the subject of Antibody. Nuclear Medicine and Biology facilitates discussions on Biodistribution that incorporate concepts from other fields like Pharmacokinetics, Cancer research, Positron emission tomography, Nuclear medicine and Radiochemistry.

Some problems in Radiochemistry that were presented in the journal overlapped with concepts under Yield (chemistry) and Radiosynthesis. It holds forums on Stereochemistry that merges themes from other disciplines such as Ligand (biochemistry), Chelation, Ligand, High-performance liquid chromatography and Chemical synthesis. Metabolism is part of Biochemistry studies tackled in Nuclear Medicine and Biology.

• In vivo (28.52%)
• Biodistribution (23.79%)
• Stereochemistry (15.15%)

What are the most cited papers published in the journal?

• Efficient production of high specific activity 64Cu using a biomedical cyclotron. (440 citations)
• Anatomy of SUV (385 citations)
• Copper radionuclides and radiopharmaceuticals in nuclear medicine (345 citations)

Research areas of the most cited articles at Nuclear Medicine and Biology:

The main points discussed in the journal papers deal with In vivo, Biodistribution, Biochemistry, Nuclear medicine and In vitro. The published papers with studies in In vivo featured incorporate elements of Pathology, Receptor, Internal medicine, Molecular biology and Stereochemistry. The published papers focus on Biodistribution but sometimes tackle the closely related topic of Radiochemistry which is concerned with High-performance liquid chromatography and Nuclear chemistry.

What topics the last edition of the journal is best known for?

• Internal medicine
• Enzyme
• Cancer

The previous edition focused in particular on these issues:

The concepts of Cancer research, In vivo, Radiochemistry, Combinatorial chemistry and Pet imaging are tackled in the journal. Issues in Cancer research were discussed, taking into consideration concepts from other disciplines like Prostate cancer and Radionuclide therapy. The work on In vivo tackled in the journal brings together disciplines like In vitro, Stereochemistry and Pharmacology.

The in-depth study on Radiochemistry also explores topics in the intersecting field of DOTA. Biodistribution and Ex vivo are closely related fields of research discussed in Nuclear Medicine and Biology.

The most cited articles from the last journal are:

• Review on 99mTc radiopharmaceuticals with emphasis on new advancements (13 citations)
• The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review. (12 citations)
• The development of 11C-carbonylation chemistry: A systematic view. (11 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Nuclear Medicine and Biology (based on the number of publications) are:

• Michael J. Welch (85 papers) absent at the last edition,
• Hank F. Kung (67 papers) published 3 papers at the last edition the same number as at the previous edition,
• Michael R. Zalutsky (63 papers) published 4 papers at the last edition, 3 more than at the previous edition,
• Christer Halldin (60 papers) absent at the last edition,
• Michael R. Kilbourn (48 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Nuclear Medicine and Biology (based on the number of publications) are:

• Washington University in St. Louis (140 papers) absent at the last edition,
• National Institutes of Health (107 papers) absent at the last edition,
• University of Missouri (90 papers) published 2 papers at the last edition,
• University of Pennsylvania (87 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• National Institute of Radiological Sciences (82 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 69.65% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.23% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.54% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.36% of all publications and 44.87% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.